Impact of bioactive peptides on neurodegenerative diseases: Biochemical pathways and potential therapies

Read full text Summarise with VIRAT
Authors: Henrik Johansson
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Bioactive peptides represent a promising frontier in the search for effective interventions against neurodegenerative diseases, yet comparative data across peptide families remain scarce. This research investigated the neuroprotective properties of three distinct peptide classes-carnosine, glutathione-derived peptides, and humanin analogues-using both in vitro neuronal cultures and clinical biomarker analyses from patients diagnosed with Alzheimer's disease and Parkinson's disease. We recruited 75 participants across two Swedish academic medical centers between April 2019 and October 2020, assigning 38 to the peptide supplementation group and 37 to matched controls. Cell viability assays, reactive oxygen species measurements, caspase-3 activity quantification, and tau protein analysis formed the core of our analytical framework. Carnosine at 50 µM concentration showed a 43.7% reduction in oxidative stress markers compared to untreated controls (p

Fields of Study & Subjects

Biochemical effects in animals Alzheimer's disease research and treatments Protein Hydrolysis and Bioactive Peptides

Publication details

Journal / source
International Journal of Advanced Biochemistry Research
Volume
10
Issue
3
Pages
876–882
Publication date
1 March 2026
Language
EN